The trend and the disease prediction of vascular endothelial growth factor and placenta growth factor in nontuberculous mycobacterial lung disease
- PMID: 27876856
- PMCID: PMC5120340
- DOI: 10.1038/srep37266
The trend and the disease prediction of vascular endothelial growth factor and placenta growth factor in nontuberculous mycobacterial lung disease
Abstract
Nontuberculous mycobacteria (NTM)-lung disease (LD) is an increasing health problem worldwide. The diagnosis of this disease remains difficult, however the application of placenta growth factor (PlGF) and vascular endothelial growth factor (VEGF) has not yet been studied. We screened patients with Mycobacterium avium complex or M. abscessus isolated from sputum, and enrolled 32 patients with NTM-LD and 93 with NTM pulmonary colonization. The NTM-LD group had a lower body mass index, higher proportion of bronchiectasis, more respiratory symptoms and pulmonary lesions, and higher titers of sputum acid-fast stain than the NTM pulmonary colonization group. The plasma level of PlGF was lower in the NTM-LD group than in the NTM colonization group, whereas the level of VEGF was higher in the NTM-LD group. In multivariable logistic regression analysis excluding NTM cultures, the predictive model for NTM-LD included sputum AFS titer, a nodular-bronchiectasis radiographic pattern, plasma VEGF/PlGF ratio, and chest radiographic score (VEGF/P1GF ratio became not significant as a factor in multivariable generalized linear model). The four-factor predictive index had good positive likelihood ratio and negative likelihood ratio for predicting NTM-LD in the patients with NTM in their sputum.
Conflict of interest statement
The authors declare no competing financial interests.
Figures



Similar articles
-
Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.Antimicrob Agents Chemother. 2018 Sep 24;62(10):e01105-18. doi: 10.1128/AAC.01105-18. Print 2018 Oct. Antimicrob Agents Chemother. 2018. PMID: 30104265 Free PMC article.
-
Use of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease.Int J Tuberc Lung Dis. 2011 Oct;15(10):1415-20. doi: 10.5588/ijtld.10.0786. Int J Tuberc Lung Dis. 2011. PMID: 22283904
-
Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination.Clin Microbiol Infect. 2015 Mar;21(3):250.e1-7. doi: 10.1016/j.cmi.2014.08.025. Epub 2014 Oct 29. Clin Microbiol Infect. 2015. PMID: 25658545
-
Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic review.J Formos Med Assoc. 2020 Jun;119 Suppl 1:S4-S12. doi: 10.1016/j.jfma.2020.05.019. Epub 2020 May 30. J Formos Med Assoc. 2020. PMID: 32482605
-
Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients.Korean J Radiol. 2002 Jul-Sep;3(3):145-57. doi: 10.3348/kjr.2002.3.3.145. Korean J Radiol. 2002. PMID: 12271159 Free PMC article. Review.
Cited by
-
Treatment Outcome in Patients with Mycobacterium abscessus Complex Lung Disease: The Impact of Tigecycline and Amikacin.Antibiotics (Basel). 2022 Apr 25;11(5):571. doi: 10.3390/antibiotics11050571. Antibiotics (Basel). 2022. PMID: 35625215 Free PMC article.
References
-
- Field S. K. & Cowie R. L. Lung disease due to the more common nontuberculous mycobacteria. Chest 129, 1653–1672 (2006). - PubMed
-
- Griffith D. E. et al.. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175, 367–416 (2007). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials